Suture-anchored cutaneous tension induces persistent hypertrophic scarring in a novel murine model

Abstract

Background: Hypertrophic scars cause impaired skin appearance and function, seriously affecting physical and mental health. Due to medical ethics and clinical accessibility, the collection of human scar specimens is frequently restricted, and the establishment of scar experimental animal models for scientific research is urgently needed. The four most commonly used animal models of hypertrophic scars have the following drawbacks: the rabbit ear model takes a long time to construct; the immunodeficient mouse hypertrophic scar model necessitates careful feeding and experimental operations; female Duroc pigs are expensive to purchase and maintain, and their large size makes it difficult to produce a significant number of models; and mouse scar models that rely on tension require special skin stretch devices, which are often damaged and shed, resulting in unstable model establishment. Our group overcame the shortcomings of previous scar animal models and created a new mouse model of hypertrophic scarring induced by suture anchoring at the wound edge. Methods: We utilized suture anchoring of incisional wounds to impose directional tension throughout the healing process, restrain wound contraction, and generate granulation tissue, thus inducing scar formation. Dorsal paired incisions were generated in mice, with wound edges on the upper back sutured to the rib cage and the wound edges on the lower back relaxed as a control. Macroscopic manifestation, microscopic histological analysis, mRNA sequencing, bioinformatics, and in vitro cell assays were also conducted to verify the reliability of this method. Results: Compared with those in relaxed controls, the fibrotic changes in stretched wounds were more profound. Histologically, the stretched scars were hypercellular, hypervascular, and hyperproliferative with disorganized extracellular matrix deposition, and displayed molecular hallmarks of hypertrophic fibrosis. In addition, the stretched scars exhibited transcriptional overlap with mechanically stretched scars, and human hypertrophic and keloid scars. Phosphatidylinositol 3-kinase-serine/threonine-protein kinase B signaling was implicated as a profibrotic mediator of apoptosis resistance under suture-induced tension. Conclusions: This straightforward murine model successfully induces cardinal molecular and histological features of pathological hypertrophic scarring through localized suture tension to inhibit wound contraction. The model enables us to interrogate the mechanisms of tension-induced fibrosis and evaluate anti-scarring therapies.

Keywords

hypertrophic scar / mouse model / mRNA sequencing / fibrosis / phosphatidylinositol 3-kinase-serine/threonine-protein kinase B

References

[1] Tanaka Y, Miyamoto T, Naito Y, Yoshitake S, Sasahara A, Miyaji K. Randomized study of a new noninvasive skin closure device for use after congenital heart operations. Ann Thorac Surg 2016; 102: 1368-74. https://doi.org/10.1016/j.athoracsur.2016.03.072.

[2] Min P, Zhang S, Sinaki DG, Yao P, Hu F, Wang X, et al. Using Zhang’s supertension-relieving suture technique with slowly-absorbable barbed sutures in the management of pathological scars: a multicenter retrospective study. Burns Trauma 2023; 11: tkad026. https://doi.org/10.1093/burnst/tkad026.

[3] Wang YF, Yang YT, Chen ZA, Wu XL. The running barbed tension-offloading suture: an updated technique update on tension wound closure. Asian J Surg 2023; 46: 3773-6. https://doi.org/10.1016/j.asjsur.2023.05.114.

[4] Zhang Q, Shi L, He H, Liu X, Huang Y, Xu D, et al. Down-regulating scar formation by microneedles directly via a mechanical communication pathway. ACS Nano 2022; 16: 10163-78. https://doi.org/10.1021/acsnano.1c11016.

[5] Wang R, Chen B, Wei H, Yan W, Wu Y, Wang C, et al. Collecting and deactivating TGF-beta1 hydrogel for anti-scarring therapy in post-glaucoma filtration surgery. Mater Today Bio 2022; 14: 100260. https://doi.org/10.1016/j.mtbio.2022.100260.

[6] Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007; 179: 1311-23. https://doi.org/10.1083/jcb.200704042.

[7] Wong VW, Paterno J, Sorkin M, Glotzbach JP, Levi K, Januszyk M, et al. Mechanical force prolongs acute inflammation via T-cell-dependent pathways during scar formation. FASEB J 2011; 25: 4498-510. https://doi.org/10.1096/fj.10-178087.

[8] Wong VW, Rustad KC, Akaishi S, Sorkin M, Glotzbach JP, Januszyk M, et al. Focal adhesion kinase links mechanical force to skin fibrosis via inflammatory signaling. Nat Med 2011; 18: 148-52. https://doi.org/10.1038/nm.2574.

[9] Velasquez LS, Sutherland LB, Liu Z, Grinnell F, Kamm KE, Schneider JW, et al. Activation of MRTF-A-dependent gene expression with a small molecule promotes myofibroblast differentiation and wound healing. Proc Natl Acad Sci USA 2013; 110: 16850-5. https://doi.org/10.1073/pnas.1316764110.

[10] Francisco J, Zhang Y, Jeong JI, Mizushima W, Ikeda S, Ivessa A, et al. Blockade of fibroblast YAP attenuates cardiac fibrosis and dysfunction through MRTF-A inhibition. JACC Basic Transl Sci 2020; 5: 931-45. https://doi.org/10.1016/j.jacbts.2020.07.009.

[11] Garoffolo G, Casaburo M, Amadeo F, Salvi M, Bernava G, Piacentini L, et al. Reduction of cardiac fibrosis by interference with YAP-dependent transactivation. Circ Res 2022; 131: 239-57. https://doi.org/10.1161/CIRCRESAHA.121.319373.

[12] Ragazzini S, Scocozza F, Bernava G, Auricchio F, Colombo GI, Barbuto M, et al. Mechanosensor YAP cooperates with TGF-beta1 signaling to promote myofibroblast activation and matrix stiffening in a 3D model of human cardiac fibrosis. Acta Biomater 2022; 152: 300-12.

[13] Mascharak S, des Jardins-Park HE, Davitt MF, Griffin M, Borrelli MR, Moore AL, et al. Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. Science 2021; 372: 348-357. https://doi.org/10.1126/science.aba2374.

[14] Sun L, Zhang X, Wu S, Liu Y, Guerrero-Juarez CF, Liu W, et al. Dynamic interplay between IL-1 and WNT pathways in regulating dermal adipocyte lineage cells during skin development and wound regeneration. Cell Rep 2023; 42: 112647. https://doi.org/10.1016/j.celrep.2023.112647.

[15] Kloeters O, Tandara A, Mustoe TA. Hypertrophic scar model in the rabbit ear: a reproducible model for studying scar tissue behavior with new observations on silicone gel sheeting for scar reduction. Wound Repair Regen 2007; 15: S40-5. https://doi.org/10.1111/j.1524-475X.2007.00224.x.

[16] Momtazi M, Kwan P, Ding J, Anderson CC, Honardoust D, Goekjian S, et al. A nude mouse model of hypertrophic scar shows morphologic and histologic characteristics of human hypertrophic scar. Wound Repair Regen 2013; 21: 77-87. https://doi.org/10.1111/j.1524-475X.2012.00856.x.

[17] Li J, Ng SK, Xi W, Zhang Z, Wang X, Li H, et al. Efficacy and safety of a dual-scan protocol for carbon dioxide laser in the treatment of split-thickness skin graft contraction in a red Duroc pig model. Burns Trauma 2021; 9: tkab048. https://doi.org/10.1093/burnst/tkab048.

[18] Chen JS, Longaker MT, Gurtner GC. Murine models of human wound healing. Methods Mol Biol 2013; 1037: 265-74. https://doi.org/10.1007/978-1-62703-505-7_15.

[19] Wong VW, Sorkin M, Glotzbach JP, Longaker MT, Gurtner GC. Surgical approaches to create murine models of human wound healing. J Biomed Biotechnol 2011; 2011: 969618. https://doi.org/10.1155/2011/969618.

[20] Wang X, Ge J, Tredget EE, Wu Y. The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat Protoc 2013; 8: 302-9. https://doi.org/10.1038/nprot.2013.002.

[21] Aarabi S, Bhatt KA, Shi Y, Paterno J, Chang EI, Loh SA, et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J 2007; 21: 3250-61. https://doi.org/10.1096/fj.07-8218com.

[22] Claytor RB, Sheck CG, Chopra V. Microneedling outcomes in early postsurgical scars. Plast Reconstr Surg 2022; 150: 557e-61. https://doi.org/10.1097/PRS.0000000000009466.

[23] Zhou S, Wang W, Zhou S, Zhang G, He J, Li Q. A novel model for cutaneous wound healing and scarring in the rat. Plast Reconstr Surg 2019; 143: 468-77. https://doi.org/10.1097/PRS.0000000000005274.

[24] Wietecha MS, Pensalfini M, Cangkrama M, Muller B, Jin J, Brinckmann J, et al. Activin-mediated alterations of the fibroblast transcriptome and matrisome control the biomechanical properties of skin wounds. Nat Commun 2020; 11: 2604.

[25] Li Y, Wang J, Wang Y, He W, Zhang Y, Liu Y. IL-1beta/NF-kappaB signaling inhibits IGF-1 production via let-7f-5p in dendritic epidermal T cells. J Leukoc Biol 2022; 112: 1677-90. https://doi.org/10.1002/JLB.3MA0322-171R.

[26] Achterberg VF, Buscemi L, Diekmann H, Smith-Clerc J, Schwengler H, Meister JJ, et al. The nano-scale mechanical properties of the extracellular matrix regulate dermal fibroblast function. J Invest Dermatol 2014; 134: 1862-72. https://doi.org/10.1038/jid.2014.90.

[27] George N, Fexova S, Fuentes AM, Madrigal P, Bi Y, Iqbal H, et al. Expression atlas update: insights from sequencing data at both bulk and single cell level. Nucleic Acids Res 2023; 52: D107-14. https://doi.org/10.1093/nar/gkad1021.

[28] Ye C, Zhu J, Wang J, Chen D, Meng L, Zhan Y, et al. Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia. Clin Transl Med 2022; 12: e1070. https://doi.org/10.1002/ctm2.1070.

[29] Naba A, Clauser KR, Ding H, Whittaker CA, Carr SA, Hynes RO. The extracellular matrix: tools and insights for the "omics" era. Matrix Biol 2016; 49: 10-24. https://doi.org/10.1016/j.matbio.2015.06.003.

[30] Shay T, Kang J. Immunological genome project and systems immunology. Trends Immunol 2013; 34: 602-9. https://doi.org/10.1016/j.it.2013.03.004.

[31] Zhao S, Liu H, Wang H, He X, Tang J, Qi S, et al. Inhibition of phosphatidylinositol 3-kinase catalytic subunit alpha by miR-203a-3p reduces hypertrophic scar formation via phosphatidylinositol 3-kinase/AKT/mTOR signaling pathway. Burns Trauma 2024; 12: tkad048. https://doi.org/10.1093/burnst/tkad048.

[32] Kwansa AL, De Vita R, Freeman JW. Mechanical recruitment of N-and C-crosslinks in collagen type I. Matrix Biol 2014; 34: 161-9. https://doi.org/10.1016/j.matbio.2013.10.012.

[33] Wang ZC, Zhao WY, Cao Y, Liu YQ, Sun Q, Shi P, et al. The roles of inflammation in keloid and hypertrophic scars. Front Immunol 2020; 11: 603187. https://doi.org/10.3389/fimmu.2020.603187.

[34] Limandjaja GC, Belien JM, Scheper RJ, Niessen FB, Gibbs S. Hypertrophic and keloid scars fail to progress from the CD34(−)/alpha-smooth muscle actin (alpha-SMA)(+) immature scar phenotype and show gradient differences in alpha-SMA and p16 expression. Br J Dermatol 2020; 182: 974-86. https://doi.org/10.1111/bjd.18219.

[35] Cheng L, Sun X, Zhao X, Wang L, Yu J, Pan G, et al. Surface biofunctional drug-loaded electrospun fibrous scaffolds for comprehensive repairing hypertrophic scars. Biomaterials 2016; 83: 169-81. https://doi.org/10.1016/j.biomaterials.2016.01.002.

[36] Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 2008; 128: 1298-310. https://doi.org/10.1038/sj.jid.5701149.

[37] Agrawal A, Ding J, Agrawal B, Kwan PO, Tredget EE. Stimulation of toll-like receptor pathways by burn eschar tissue as a possible mechanism for hypertrophic scarring. Wound Repair Regen 2021; 29: 810-9. https://doi.org/10.1111/wrr.12940.

[38] Rinkevich Y, Walmsley GG, Hu MS, Maan ZN, Newman AM, Drukker M, et al. Skin fibrosis. Identification and isolation of a dermal lineage with intrinsic fibrogenic potential. Science 2015; 348: aaa2151.

[39] Bergmeier V, Etich J, Pitzler L, Frie C, Koch M, Fischer M, et al. Identification of a myofibroblast-specific expression signature in skin wounds. Matrix Biol 2018; 65: 59-74. https://doi.org/10.1016/j.matbio.2017.07.005.

[40] Shook BA, Wasko RR, Rivera-Gonzalez GC, Salazar-Gatzimas E, Lopez-Giraldez F, Dash BC, et al. Myofibroblast proliferation and heterogeneity are supported by macrophages during skin repair. Science 2018; 362: 891-899. https://doi.org/10.1126/science.aar2971.

[41] Hahn JM, Glaser K, McFarland KL, Aronow BJ, Boyce ST, Supp DM. Keloid-derived keratinocytes exhibit an abnormal gene expression profile consistent with a distinct causal role in keloid pathology. Wound Repair Regen 2013; 21: 530-44. https://doi.org/10.1111/wrr.12060.

[42] Song Y, Guo B, Ma S, Chang P, Tao K. Naringin suppresses the growth and motility of hypertrophic scar fibroblasts by inhibiting the kinase activity of Akt. Biomed Pharmacother 2018; 105: 1291-8. https://doi.org/10.1016/j.biopha.2018.06.103.

[43] Wang Y, Liu M, Zhang W, Liu H, Jin F, Mao S, et al. Mechanical strategies to promote vascularization for tissue engineering and regenerative medicine. Burns Trauma 2024; 12: tkae039. https://doi.org/10.1093/burnst/tkae039.

[44] Chen M, Yu Y, Mi T, Guo Q, Xiang B, Tian X, et al. MK-2206 alleviates renal fibrosis by suppressing the Akt/mTOR Signaling pathway In vivo and In vitro. Cells 2022; 11. https://doi.org/10.3390/cells11213505.

[45] Li J, Wang J, Wang Z, Xia Y, Zhou M, Zhong A, et al. Experimental models for cutaneous hypertrophic scar research. Wound Repair Regen 2020; 28: 126-44. https://doi.org/10.1111/wrr.12760.

[46] Wang J, Hu K, Cai X, Yang B, He Q, Wang J, et al. Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis. Acta Pharm Sin B 2022; 12: 18-32. https://doi.org/10.1016/j.apsb.2021.07.023.

[47] Zhang Q, Wang L, Wang S, Cheng H, Xu L, Pei G, et al. Signaling pathways and targeted therapy for myocardial infarction. Signal Transduct Target Ther 2022; 7: 78.

[48] Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H, et al. PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Lab Investig 2020; 100: 801-11. https://doi.org/10.1038/s41374-020-0404-9.

[49] Cong LH, Li T, Wang H, Wu YN, Wang SP, Zhao YY, et al. IL-17A-producing T cells exacerbate fine particulate matter-induced lung inflammation and fibrosis by inhibiting PI3K/Akt/mTOR-mediated autophagy. J Cell Mol Med 2020; 24: 8532-44. https://doi.org/10.1111/jcmm.15475.

[50] Xu Y, Wang X, Han D, Wang J, Luo Z, Jin T, et al. Revealing the mechanism of Jiegeng decoction attenuates bleomycin-induced pulmonary fibrosis via PI3K/Akt signaling pathway based on lipidomics and transcriptomics. Phytomedicine 2022; 102: 154207. https://doi.org/10.1016/j.phymed.2022.154207.

[51] Zhang Z, Shang J, Yang Q, Dai Z, Liang Y, Lai C, et al. Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism. J Nanobiotechnology 2023; 21: 29.